Clinical Trial Update: A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of two Japanese Encephalitis vaccines, ChimeriVax-JE and JE-VAX, has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• ChimeriVax-JE (live attenuated Japanese encephalitis vaccine)
• JE-VAX

Snippet

Sponsor: Sanofi | Conditions: Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2012-12-05